Video Experimental Relacionado
Updated: Sep 9, 2025
04:40
Identifying Coronary Artery Calcification on Non-gated Computed Tomography Scans
Published on: August 28, 2018
15.3K
Gota, ácido úrico y enfermedad arterial coronaria
Takuya Nakahashi1, Hayato Tada2, Kenji Sakata2
1Division of Cardiology, Department of Internal Medicine, Takaoka City Hospital.
Journal of atherosclerosis and thrombosis
|August 31, 2025
Resumen
Un nivel alto de ácido úrico sérico (hiperuricemia) está relacionado con enfermedades cardiovasculares y mortalidad. Identificar a los pacientes que se benefician de la reducción del ácido úrico es crucial para controlar el riesgo cardiovascular residual.
Área de la Ciencia:
- Cardiología
- La bioquímica
- Reumatología
Sus antecedentes:
- La hiperuricemia, definida como ácido úrico sérico (UA) > 7,0 mg/dL, es un precursor de la gota.
- Está asociada con hipertensión, diabetes, dislipidemia y aumento de la mortalidad.
- La UA elevada se correlaciona con marcadores de aterosclerosis y disfunción endotelial, lo que sugiere un vínculo patógeno con eventos cardiovasculares.
Objetivo del estudio:
- Revisar el conocimiento actual de la hiperuricemia en la enfermedad arterial coronaria (EAC).
- Discutir las perspectivas futuras para el manejo de la hiperuricemia como factor de riesgo residual en pacientes con EAC.
Principales métodos:
- Revisión de la literatura sobre la evidencia actual sobre la hiperuricemia y las enfermedades cardiovasculares.
- Análisis de los vínculos patógenos entre la UA elevada y los eventos cardiovasculares adversos.
- Examen de la gota, deposición de cristales de urato monosódico (MSU) y las implicaciones cardiovasculares.
Principales resultados:
- La hiperuricemia está relacionada con el aumento de las enfermedades cardiovasculares (ECV) y la mortalidad.
- La deposición de cristales de MSU puede ocurrir en las arterias coronarias, no solo en las articulaciones.
- Las terapias actuales para reducir los niveles de urato no han demostrado su eficacia en la reducción de los eventos cardiovasculares relacionados con la hiperuricemia.
Conclusiones:
- La hiperuricemia representa un riesgo residual significativo en pacientes con EAC.
- Es fundamental identificar los subgrupos específicos de pacientes que se benefician de la reducción de la UA.
- Se necesitan más investigaciones para establecer estrategias efectivas de manejo de la hiperuricemia en la EAC.
Videos de Conceptos Relacionados
01:30Coronary Artery Disease I: Introduction
54
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
54
01:26Coronary Artery Disease IV: Preventive Measures
32
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
32
01:26Coronary Artery Disease II: Pathophysiology
33
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
33
01:27Coronary Artery Disease V: Interprofessional Care
30
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
30
01:30Coronary Artery Disease III: Clinical Manifestations
31
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
31
01:30Peripheral Artery Disease I: Introduction
32
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
32